Device helps restore blood flow to the brain after a stroke, may help doctors save more lives SAO PAULO, BRAZIL--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today ...
International health care products major Covidien’s (NYSE:COV - News) Solitaire FR revascularization device has been cleared for investigational use in the Interventional Management of Stroke (“IMS ...
Covidien (Mansfield, Massachusetts) reported that the Solitaire FR revascularization device has been cleared by FDA. The device is intended to restore blood flow to the brain in patients suffering ...
March 6, 2012 — The US Food and Drug Administration (FDA) has granted approval for a new clot retrieval system, the Solitaire Flow Restoration (FR) device (Covidien), the company has announced. The ...
Two-Year Clinical Study Supports Safety and Efficacy of Covidien Solitaire™ FR Revascularization Dev
STAR Study Reviews Device Use in Blood Clot Removal Treatment for Patients Experiencing Acute Ischemic Stroke Covidien's Solitaire FR device is designed to restore blood flow in patients experiencing ...
Covidien gained Canadian approval for its Solitaire FR device.--Courtesy of Covidien Covidien ($COV) may have U.S. and regulatory approvals in place for its Solitaire ...
Nashville, Tennessee — In patients with acute ischemic stroke patients who have confirmed large vessel anterior circulation occlusions treated with thrombolysis, rapid treatment with the Solitaire FR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results